We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$62.7B
Turnover
25.36%
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$55.1B
AUM Growth
-$3.71B
(-6.3%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261
Avg Time Held Equity + Options
1.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$185M |
| 2 |
PepsiCo
PEP
|
+$176M |
| 3 |
TE Connectivity
TEL
|
+$166M |
| 4 |
Ford
F
|
+$131M |
| 5 |
3M
MMM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$352M |
| 3 |
Amazon
AMZN
|
+$296M |
| 4 |
NVIDIA
NVDA
|
+$237M |
| 5 |
Eaton
ETN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Miscellaneous | 14.37% |
| 3 | Financials | 10.33% |
| 4 | Healthcare | 9.99% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1776
Vita Coco
COCO
$3.34B
| $934K | ﹤0.01% |
19,501
+11,569
| +146% | +$631K |
2023 Q4
9 quarters
|
|
1777
Simmons First National
SFNC
$3.22B
| $934K | ﹤0.01% |
+48,031
| New | +$959K |
2026 Q1
0 quarters
|
|
1778
Agenus
AGEN
$302M
| $932K | ﹤0.01% |
278,980
+164,776
| +144% | +$547K |
2025 Q4
1 quarter
|
|
1779
Northpointe Bancshares
NPB
$540M
| $931K | ﹤0.01% |
53,956
+42,806
| +384% | +$753K |
2025 Q4
1 quarter
|
|
1780
DELISTED
Esperion Therapeutics
ESPR
| $931K | ﹤0.01% |
+339,775
| New | +$1.08M |
2026 Q1
0 quarters
|
|
1781
Align Technology
ALGN
$10.6B
| $922K | ﹤0.01% |
5,380
+3,009
| +127% | +$527K |
2023 Q4
9 quarters
|
|
1782
Curbline Properties
CURB
$3.06B
| $919K | ﹤0.01% |
+35,643
| New | +$913K |
2026 Q1
0 quarters
|
|
1783
Omnicell
OMCL
$1.64B
| $916K | ﹤0.01% |
+27,439
| New | +$1.15M |
2026 Q1
0 quarters
|
|
1784
Tenable Holdings
TENB
$4.33B
| $915K | ﹤0.01% |
54,095
-150,572
| -74% | -$3.16M |
2023 Q4
9 quarters
|
|
1785
Dorian LPG
LPG
$2.3B
| $911K | ﹤0.01% |
26,644
+7,993
| +43% | +$253K |
2025 Q3
2 quarters
|
|
1786
CALL
Bristol-Myers Squibb
BMY
$124B
| $910K | ﹤0.01% |
15,000
| – | – |
2025 Q4
1 quarter
|
|
|
1787
PUT
Bristol-Myers Squibb
BMY
$124B
| $910K | ﹤0.01% |
15,000
| – | – |
2025 Q4
1 quarter
|
|
1788
Empire State Realty Trust
ESRT
$819M
| $910K | ﹤0.01% |
+174,936
| New | +$1.05M |
2026 Q1
0 quarters
|
|
1789
Matador Resources
MTDR
$6.65B
| $908K | ﹤0.01% |
+14,368
| New | +$720K |
2026 Q1
0 quarters
|
|
1790
Xcel Energy
XEL
$46.9B
| $906K | ﹤0.01% |
11,409
-43,046
| -79% | -$3.38M |
2023 Q4
9 quarters
|
|
1791
Guardant Health
GH
$22.3B
| $894K | ﹤0.01% |
9,683
-286,121
| -97% | -$28.7M |
2024 Q3
6 quarters
|
|
1792
CONMED
CNMD
$1.41B
| $894K | ﹤0.01% |
+25,281
| New | +$1.03M |
2026 Q1
0 quarters
|
|
1793
Reynolds Consumer Products
REYN
$4.78B
| $889K | ﹤0.01% |
+41,956
| New | +$962K |
2026 Q1
0 quarters
|
|
1794
TripAdvisor
TRIP
$1.1B
| $886K | ﹤0.01% |
83,130
+59,528
| +252% | +$693K |
2025 Q4
1 quarter
|
|
1795
Signet Jewelers
SIG
$4.53B
| $886K | ﹤0.01% |
10,464
-33,066
| -76% | -$3.01M |
2025 Q4
1 quarter
|
|
1796
Hallador Energy
HNRG
$599M
| $883K | ﹤0.01% |
54,262
+24,293
| +81% | +$453K |
2025 Q3
2 quarters
|
|
1797
Mobileye
MBLY
$6.32B
| $883K | ﹤0.01% |
128,525
+37,837
| +42% | +$343K |
2025 Q3
2 quarters
|
|
1798
Lamb Weston
LW
$7.47B
| $882K | ﹤0.01% |
20,881
+11,581
| +125% | +$517K |
2025 Q2
3 quarters
|
|
1799
JBT Marel
JBTM
$5.5B
| $881K | ﹤0.01% |
6,893
-15,979
| -70% | -$2.42M |
2025 Q3
2 quarters
|
|
1800
AMC Entertainment Holdings
AMC
$2.7B
| $877K | ﹤0.01% |
+894,445
| New | +$1.15M |
2026 Q1
0 quarters
|
|
Similar funds
Man Group's Q1 2026 Portfolio in Review
As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Man Group withdrew a net $2.01B in Q1 2026, closing 261 positions and reducing 775 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Man Group opened a new position in AstraZeneca worth $122M.
- Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
- Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
- Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
- Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
- Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
- Man Group opened 414 new positions and closed 261 in Q1 2026.
- Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.